Gold Fields Limited vs Nuwellis Inc — how do they compare? Gold Fields Limited trades at $37.08 (market cap $31.87B), while Nuwellis Inc trades at $0.68 (market cap $2.20M). The key difference: Gold Fields Limited is far larger — about 14486.4× Nuwellis Inc's market cap, and Gold Fields Limited pays a 6% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gold Fields Limited for 49 Days and Nuwellis Inc for 26 Days on average.
| GFI | NUWE | |
|---|---|---|
Market Cap | $31.87B | $2.20M |
Volume | 4,169,651 | 121,544 |
Sector | Basic Materials | Health |
52-Week High | $61.52 | $146.65 |
52-Week Low | $31.25 | $0.68 |
Typical Hold Time | 49 Days | 26 Days |
Enterprise Value | $32.47B | -$1.52M |
Dividend Yield | 6% | — |
Signals from Pluang's Aura AI — not financial advice
Gold Fields (GFI) trades at $35.05, down 3.1% amid market reaction to its rejected $27 billion takeover bid for Northern Star. The stock shows strong fundamentals with a P/E of 7.14, robust 38.66% net margin, and record 2025 revenue of $8.75B. Technical indicators are bearish with moving averages signaling sell pressure, though RSI suggests potential oversold conditions. Recent earnings show mixed results with one beat and three misses against expectations.
The outlook remains positive with analyst consensus target of $52.75 (51% upside) and no sell ratings. Key risks include acquisition execution challenges and gold price volatility. The company's strong cash flow generation ($3.77B operating cash flow) and shareholder returns ($1.25B program) support long-term value despite near-term acquisition uncertainty.
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Gold Fields Ltd is a producer of gold and is a holder of gold reserves and resources in South Africa, Ghana, Australia and Peru. In Peru, the company also produces copper. The company is primarily involved in underground and surface gold and surface copper mining and silver and related activities, including exploration, extraction, processing and smelting. It conducts underground and surface mining operations at St. Ives, underground-only operations at Agnew, Granny Smith and South Deep and surface-only open pit mining at Damang, Tarkwa and Cerro Corona. The company's revenues are derived from the sale of gold that it produces.
Read more on GFI →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →